These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4055938)

  • 1. Reversed-phase liquid chromatographic investigation of nucleosides and bases in mucosa and modified nucleosides in urines from patients with gastrointestinal cancer.
    Nakano K; Shindo K; Yasaka T; Yamamoto H
    J Chromatogr; 1985 Sep; 332():127-37. PubMed ID: 4055938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients.
    Nakano K; Shindo K; Yasaka T; Yamamoto H
    J Chromatogr; 1985 Sep; 343(1):21-33. PubMed ID: 4066857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and identification of urinary nucleosides. Applications of high-performance liquid chromatographic methods to the synthesis of 5'-deoxyxanthosine and the simultaneous determination of 5,6-dihydrouridine and pseudouridine.
    Nakano K; Yasaka T; Schram KH; Reimer ML; McClure TD; Nakao T; Yamamoto H
    J Chromatogr; 1990 Aug; 515():537-46. PubMed ID: 2283377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
    Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
    Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
    Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
    Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM; Di Stefano C; Wixforth A; Schmid HR
    J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
    Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA; Grever MR; Speicher CE; Trewyn RW
    J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography].
    Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW
    Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of pseudouridine in tRNA and in acid-soluble tissue extracts by high-performance liquid chromatography.
    Russo T; Salvatore F; Cimino F
    J Chromatogr; 1984 Jul; 296():387-93. PubMed ID: 6480746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
    Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Dudley E; Lemière F; Van Dongen W; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2004; 18(22):2730-8. PubMed ID: 15499664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients.
    Liebich HM; Xu G; Di Stefano C; Lehmann R
    J Chromatogr A; 1998 Jan; 793(2):341-7. PubMed ID: 9474787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
    Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of 5-carbamoylmethyluridine and 5-carbamoylmethyl-2-thiouridine from human urine.
    Chheda GB; Patrzyc HB; Tworek HA; Dutta SP
    Nucleosides Nucleotides; 1999 Oct; 18(10):2155-73. PubMed ID: 10616723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary nucleosides as biological markers for patients with colorectal cancer.
    Zheng YF; Yang J; Zhao XJ; Feng B; Kong HW; Chen YJ; Lv S; Zheng MH; Xu GW
    World J Gastroenterol; 2005 Jul; 11(25):3871-6. PubMed ID: 15991285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.